| Literature DB >> 21076547 |
Ocilon Gomes de Sá Filho1, José Luiz Moraes Vasconcelos.
Abstract
Bos indicus cattle, the preferred genetic group in tropical climates, are characterized by having a lower reproductive efficiency than Bos taurus. The reasons for the poorer reproductive efficiency of the Bos indicus cows include longer lengths of gestation and postpartum anestrus, a short length of estrous behavior with a high incidence of estrus occurring during the dark hours, and puberty at older age and at a higher percentage of body weight relative to mature body weight. Moreover, geography, environment, economics, and social traditions are factors contributing for a lower use of reproductive biotechnologies in tropical environments. Hormonal protocols have been developed to resolve some of the reproductive challenges of the Bos indicus cattle and allow artificial insemination, which is the main strategy to hasten genetic improvement in commercial beef ranches. Most of these treatments use exogenous sources of progesterone associated with strategies to improve the final maturation of the dominant follicle, such as temporary weaning and exogenous gonadotropins. These treatments have caused large impacts on reproductive performance of beef cattle reared under tropical areas.Entities:
Year: 2010 PMID: 21076547 PMCID: PMC2976513 DOI: 10.4061/2011/923053
Source DB: PubMed Journal: Vet Med Int ISSN: 2042-0048
Percentage of cows inseminated (first 3 d and 25 d of breeding season), conception (first 3 d and from d 4 to 25 of breeding season) and pregnancy rates (first 3 d, 25 d, and in 80 d of breeding season) in anestrous Nelore (Bos indicus) × Angus (Bos taurus) crossbred cows treated or not treated with an intravaginal insert containing 1.9 g of progesterone (CIDR) between days −7 to 0 of breeding season and/or 48 h temporary weaning (TW) between d 0 and 2 of breeding season. Adapted from Vasconcelos et al. [4].
| Dependent variable | Without CIDR | With CIDR | ||
|---|---|---|---|---|
| Without TW | With TW | Without TW | With TW | |
| % cows inseminated (3 d)bc | 2.7% (2/73) | 48.6% (34/70) | 17.8% (13/73) | 41.4% (29/70) |
| Conception (3 d)ac | 50.0% (1/2) | 8.8% (3/34) | 46.1% (6/13) | 58.6% (17/29) |
| Pregnancy rate (3 d)ab | 1.4% (1/73) | 4.3% (3/70) | 8.2% (6/73) | 24.3% (17/70) |
| Conception (4–25 d) | 50.0% (7/14) | 16.7% (2/12) | 50.0% (4/8) | 60.0% (3/5) |
| % cows inseminated (25 d)b | 21.9% (16/73) | 60.0% (42/70) | 28.8% (21/73) | 48.6% (34/70) |
| Pregnancy rate (25 d)ac | 10.9% (8/73) | 7.1% (5/70) | 13.7% (10/73) | 28.6% (20/70) |
| Pregnancy rate (80 d) | 58.9% (43/73) | 65.7% (46/70) | 61.6% (45/73) | 58.6% (41/70) |
aCIDR (P < .05); bTW (P < .05); cCIDR × TW (P < .05).
Ovulation, conception, and pregnancy rates of suckled Bos indicus cows submitted to a synchronization of ovulation protocol using progesterone associated with estradiol having different dosages of PGF2α (Study 1), ovulatory stimuli (Study 2), and uses of intravaginal progesterone insert (Study 3 and 4). Adapted from Meneghetti et al. [17].
| Item | Ovulation rate | Conception rate | Pregnancy rate |
|---|---|---|---|
| Study 1-PGF2 | |||
| Half-dose | 88.7% (110/124) | 69.2% (76/110) | 61.3% (76/124) |
| Full-dose | 94.4% (119/126) | 68.2% (81/119) | 64.3% (81/126) |
| Study 2-Ovulatory stimulusb | |||
| ECP | 89.5% (282/315) | 56.7% (160/282) | 50.8% (160/315) |
| EB | 90.9% (289/318) | 57.1% (165/289) | 51.9% (165/318) |
| GnRH | 91.0% (284/312) | 59.5% (169/284) | 54.2% (169/312) |
| Study 3-CIDR usesc | |||
| CIDRn | 91.7% (496/541) | 56.0% (278/496) | 51.4% (278/541) |
| CIDR9d | 90.6% (482/532) | 59.3% (286/482) | 53.8% (286/532) |
| CIDR18d | 90.1% (373/414) | 55.8% (208/373) | 50.2% (208/414) |
| Study 4-CIDR usesc | |||
| CIDRn | 79.7% (55/69) | 54.5% (30/55) | 43.5% (30/69) |
| CIDR9d | 80.0% (144/180) | 61.1% (88/114) | 48.9% (88/180) |
| CIDR18d | 83.9% (188/224) | 60.1% (113/188) | 50.4% (113/224) |
| CIDR27d | 85.7% (90/105) | 57.8% (52/90) | 49.5% (52/105) |
aCows were treated with 12.5 mg (Half-dose) or 25 mg (Full-dose) dinoprost tromethamine on d 7 of a protocol using progesterone associated with benzoate estradiol. Progesterone devices were maintained between d 0 and 9, and fixed-time AI were performed on d 11. Ovulation was induced with estradiol benzoate administered on d 10. Dependent variables were not affected by PGF2α dosage (P > .10).
bCows were treated with estradiol cypionate (ECP) on d 9, estradiol benzoate (EB) on d 10, or gonadotropin releasing (GnRH) hormone on d 11 relative to initiation of a protocol using progesterone associated with benzoate estradiol. Progesterone devices were maintained between d 0 and 9, and fixed-time AI were performed on d 11. Dependent variables were not affected by ovulatory stimulus (P > .10).
cCows received a nonpreviously used CIDR (CIDRn), a CIDR used previously for 9 d (CIDR9d), a CIDR used previously for 18 d (CIDR18d), or a CIDR used previously for 27 d (CIDR27d) at initiation of the protocol. Dependent variables were not affected by CIDR type (P > .10).
Ovulation, conception, and pregnancy rates of suckled Bos indicus cows submitted to a synchronization of ovulation protocol using progesterone associated with estradiol having different strategies to improve fertility. Adapted from Sá Filho et al. [18].
| Item | Ovulation rate | Conception rate | Pregnancy rate |
|---|---|---|---|
| Study 1-eCG to replace TWa | |||
| Control | 81.9% (181/221) | 50.8% (92/181) | 41.6% (92/221) |
| eCG300 | 80.8% (168/208) | 57.7% (97/168) | 46.6% (97/208) |
| eCG400 | 83.9% (187/223) | 64.7% (121/187) | 54.3% (121/223) |
| TW | 86.6% (207/239) | 59.4% (123/207) | 51.5% (123/239) |
| Study 2-FSH to replace eCGb | |||
| TW | — | — | 41.9% (83/198) |
| eCG400 | — | — | 43.3% (81/187) |
| Folltropin | — | — | 34.3% (74/216) |
| Pluset | — | — | 32.1% (36/112) |
| Study 3-eCG associated with TWc | |||
| TW | 88.9% (264/297) | 158/264 (59.8) | 53.2% (158/297) |
| TW + eCG200 | 93.0% (278/299) | 155/278 (55.7) | 51.8% (155/299) |
| TW + eCG400 | 90.0% (261/291) | 152/261 (58.2) | 52.2% (152/291) |
aCows received no treatment (Control), 300 IU of eCG (eCG300), 400 IU of eCG (eCG400), or temporary weaning (48 h; TW) on d 9 relative to initiation of an ovulation synchronization protocol. Pregnancy rates were greater in eCG400 and TW treatments than in Control (P < .05).
bCows received temporary weaning (48 h; TW), 400 IU of eCG (eCG400), 20 mg of Folltropin (Folltropin-FSH), or 20 mg of Pluset (Pluset-FSH) on d 9 relative to initiation of an ovulation synchronization protocol. Pregnancy rates were greater in eCG400 and TW treatments than in Folltropin and Pluset (P < .05).
cCows received temporary weaning (48 h; TW), temporary weaning + 200 IU of eCG (TW + eCG200), or temporary weaning + 400 IU of eCG (TW + eCG400) on d 9 relative to initiation of an ovulation synchronization protocol. Dependent variables were not affected by treatments (P > .10).
Figure 1Cumulative percentage of pregnancy in prepubertal Bos indicus heifers throughout a 45 d AI breeding season. Heifers were assigned to receive, between d-12 and 0, no treatment (CIDR0), a new intravaginal insert (CIDR1), or a similar intravaginal insert that had previously been used three times (CIDR4). Heifers were artificially inseminated 10 to 14 h after detection of estrus; those that returned in estrus after the first service were re-inseminated. Adapted from Claro Júnior et al. [15].
Reproductive endpoints in prepubertal Bos indicus heifers that received, between d-12 and 0, no treatment (CIDR0), a new intravaginal insert containing 1.9 g of progesterone (CIDR1), or a similar intravaginal insert that had previously been used three times (CIDR4). The breeding season started on d 1 and consisted of AI after estrus detection between d 1 and 45 and exposure to bulls between d 46 and 90. Adapted from Claro Júnior et al. [15].
| Dependent variable | Treatment | ||
|---|---|---|---|
| CIDR0 | CIDR1 | CIDR4 | |
| Progesterone on d 0, ng/mLa | 0.37 ± 0.16 | 2.31 ± 0.11 | 1.20 ± 0.11 |
| Follicle diameter on d 0, mma | 9.45 ± 0.24 | 9.72 ± 0.17 | 11.42 ± 0.16 |
| Uterine score on d 0a | 1.49 ± 0.06 | 1.88 ± 0.04 | 2.24 ± 0.04 |
| Interval to estrus, da | 4.4 ± 0.28 | 3.48 ± 0.13 | 3.24 ± 0.14 |
| Estrus detection in 7 d, % (n)a | 19.5 (22/113) | 42.6 (101/237) | 39.3 (94/239) |
| Conception rate in 7 d, % (n)a | 27.3 (6/22) | 33.7 (34/101) | 46.8 (44/94) |
| Pregnancy rate in 7 d, % (n)a | 5.3 (6/113) | 14.3 (34/237) | 18.4 (44/239) |
| Estrus detection in 45 d, % (n)a | 52.2 (59/113) | 72.1 (171/237) | 75.3 (180/239) |
| Pregnancy rate in 45 d, % (n)a | 27.4 (31/113) | 39.2 (93/237) | 47.7 (114/239) |
| Pregnancy rate in 90 d, % (n)a | 72.6 (82/113) | 83.5 (198/237) | 83.7 (200/239) |
aTreatment (P < .05).
Ovulation, conception, and pregnancy rates of Bos indicus pubertal heifers (Study 1) and nonlactating cows (Study 2) submitted to a synchronization of ovulation protocol using progesterone associated with estradiol having different strategies to improve fertility. Adapted from Peres et al. [53].
| Item | Ovulation rate | Conception rate | Pregnancy rate |
|---|---|---|---|
| Study 1-CIDR uses and eCGa | |||
| CIDR 1st use/0 IU eCG | 84.3% (161/191) | 49.1% (79/161) | 41.4% (79/191) |
| CIDR 1st use/200 IU eCG | 89.9% (169/188) | 51.5% (87/169) | 46.3% (87/188) |
| CIDR 1st use/300 IU eCG | 94.6% (177/187) | 52.0% (92/177) | 49.2% (92/187) |
| CIDR 3rd use/0 IU eCG | 83.4% (176/211) | 49.4% (87/176) | 41.2% (87/211) |
| CIDR 3rd use/200 IU eCG | 87.2% (170/195) | 54.7% (93/170) | 47.7% (93/195) |
| CIDR 3rd use/300 IU eCG | 93.9% (170/185) | 47.1% (80/170) | 44.2% (80/181) |
| Study 2-Time of PGF2 | |||
| PGF2 | 80.3% (143/178) | 59.4% (85/143) | 47.7% (85/178) |
| PGF2 | 90.7% (156/172) | 62.1% (97/156) | 56.4% (97/172) |
| PGF2 | 64.4% (112/174) | 42.0% (47/112) | 27.0% (47/174) |
| PGF2 | 89.3% (159/178) | 50.9% (81/159) | 45.5% (81/178) |
aPubertal heifers received a nonpreviously used CIDR (1st use) or a CIDR used previously for 18 d (3rd use) at initiation of a TAI protocol, and 0, 200, or 300 IU of eCG on d 9 relative to CIDR insertion, in a 2 × 3 factorial design. There were effects of eCG treatment on ovulation, conception, and pregnancy rates (P < .05).
bNonlactating cows were treated with 12.5 mg of dinoprost tromethamine on d 7 (48 h before CIDR withdrawal; PGF2α d 7) or on d 9 (immediately after CIDR withdrawal; PGF2α d 9), and 0 IU of eCG or 300 IU of eCG on d 9 of an ovulation synchronization protocol. There were effects of time of PGF2α treatment on ovulation, conception, and pregnancy rates (P < .05); eCG affected ovulation and pregnancy rates (P < .05).